References
- Ahmann D. L., Hahn R. G., Bisel H. F. Evaluation of 1-(2-chloroethyl-3-4-methylcyclohexyl)-l-nitrosourea (methyl-CCNU, NSC-95441 versus combined imidazole carboxamide (NSC-45388) and vincristine (NSC-67574) in palliation of disseminated malignant melanoma. Cancer 1974; 33: 615
- Carmo-Fereira J., Costa F. O., Henriques E. Combination cytotoxic chemotherapy with procarbazine, vincristine, and lomustine (POC) in disseminated malignant melanoma: 8 years' follow-up. Cancer Treat. Rep. 1984; 68(No. 10)1211
- Comis R. L. DTIC (NSC-45388) in malignant melanoma. A perspective. Cancer Treat. Rep. 1976; 60(No. 2)165
- Costanza M. E., Nathason L., Lenhard R. Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea. Cancer 1972; 30: 1457, et coll
- Costanza M. E., Nathason L., Schoenfeld D. Results with methyl-CCNU and DTIC in metastatic melanoma. Cancer 1977; 40: 1010, et coll
- Gerner R. E., Moore G. E., Didolkar M. S. Chemotherapy of disseminated malignant melanoma with dimetyl triazeno imidazole carboxamide and dactinomycin. Cancer 1973; 32: 756
- Miller A. B., Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207
- Voigt H., Kleeberg U. R. PALA, vindesine and cisplatin combination chemotherapy in advanced malignant melanoma. A pilot study. Cancer 1984; 53: 2058
- Wittes R. E., Wittes J. T., Golbey R. B. Combination chemotherapy in metastatic malignant melanoma. Cancer 1978; 41: 415
- Young D. W., Lever R. S., English J. S. C., MacKie R. M. The use of BELD (bleomycin, vindesine, CCNU and DTIC) in advanced malignant melanoma. Cancer 1985; 55: 1879